Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy

Figure 1

(a) Description of the aetiological complexity of schizophrenia [14] (reproduced with permission from Macmillan Publishers Ltd. Nature 2010). (b) Stages of schizophrenia progression [23] (reproduced with permission from Elsevier B.V. Ltd. © 2009).

(a)

(b)